Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

Kavanaugh, Italy, Tesla and Sears

Market is slightly up across the board as we are about two hours into trading this Friday. Oil is up better than 1% as well. Odds are increasing that Justice Kavanaugh will be confirmed on Tuesday, and it will be nice to have that circus shut down a...

And We're Off and Running... Sort Of

It's a slight down open to close the week and the last trading day of the quarter. Slack looks like it will take the initial public offering (IPO) route sometime in the first half of 2019; its last financing round had the software company valued at ...

Now at the Plate, Your Pinch Hitter, Bret Jensen!

It is good to be back standing in for Doug Kass this Friday with the Daily Diary. Hopefully we see the market follow up on Thursday's rally and end the trading week on a high note. It looks like overseas markets are mixed, with Asia closing largely ...

Amarin's Huge Rally: Here's Why the Stock Is Soaring and How to Trade It

For equity holders in Amarin, now's the time to be implementing my 'Jensen Rules.'

3 Key Items to Watch in the Fourth Quarter

As Q4 fast approaches, these things have the potential to move the markets.

Consider These Diagnostic Testing Firms

Diagnostic firms can have an advantage of recurring revenue streams.

Synchrony, Exelixis Look Like Good Values

The credit card provider and the biotech concern appear cheap relative to their potential.

Ignore the Escalating Trade War

The domestic economy is performing at a level unseen in almost 2 decades.

2 Core Income Stocks Investors Can Put on Auto Pilot

These boring, low-beta income plays would be a great addition to any income seeker's portfolio.

Buy Struggling Progenics and Dynavax Here

Both biotech stocks are at or near 52-week lows, but don't deserve to be.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight